2016
DOI: 10.1016/j.neurobiolaging.2016.07.027
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a novel loss-of-function C9orf72 splice site mutation in a patient with amyotrophic lateral sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 38 publications
0
14
0
Order By: Relevance
“…Interestingly, a patient with a heterozygous splice site mutation ( c.601–2A > G) was identified using the method of targeted sequencing of coding regions. Functional analysis indicated that the splice site mutation created a premature stop codon (p. I201fsX235) with a decreased mutant messenger RNA levels, supporting the potential loss-of-function mechanism in the pathogenesis of C9ORF72 mutation (Liu et al, 2016a). …”
Section: Genetic Characteristics Of Chinese Als Patientsmentioning
confidence: 82%
See 1 more Smart Citation
“…Interestingly, a patient with a heterozygous splice site mutation ( c.601–2A > G) was identified using the method of targeted sequencing of coding regions. Functional analysis indicated that the splice site mutation created a premature stop codon (p. I201fsX235) with a decreased mutant messenger RNA levels, supporting the potential loss-of-function mechanism in the pathogenesis of C9ORF72 mutation (Liu et al, 2016a). …”
Section: Genetic Characteristics Of Chinese Als Patientsmentioning
confidence: 82%
“…Among the patients with expanded G 4 C 2 repeats, four of them were reported to have a phenotype of ALS-FTD or a family history of FTD (Jiao et al, 2014; Soong et al, 2014), another three patients exhibited cognitive impairment (Chen et al, 2016b). An intermediate length of G 4 C 2 repeats might also be pathological in Caucasian ALS patients (Byrne et al, 2014), while the phenomenon was not detected in the studies of Chinese patients (Chen et al, 2016b; Jiao et al, 2014; Liu et al, 2016a). Interestingly, a patient with a heterozygous splice site mutation ( c.601–2A > G) was identified using the method of targeted sequencing of coding regions.…”
Section: Genetic Characteristics Of Chinese Als Patientsmentioning
confidence: 93%
“…However, only a single sporadic ALS patient has ever been found to carry a mutation potentially capable of causing a heterozygous loss of function, and it is unclear if this mutation is causative of the disease state [18,19]. Additionally, a patient homozygous for the repeat expansion had a similar clinical phenotype to heterozygote patients, rather than a much more severe phenotype typical of homozygous loss of function mutations [12].…”
Section: Loss Of Functionmentioning
confidence: 99%
“…In addition to the toxicity resulting from the expanded repeat (Taylor et al 2016), the reduction in C9orf72 transcript and protein levels in patient cells and brain tissue suggests that loss-of-function mechanisms may contribute to ALS and FTD pathogenesis (DeJesus-Hernandez et al 2011;Gijselinck et al 2012;Belzil et al 2013;Ciura et al 2013;Donnelly et al 2013;Mori et al 2013;Xi et al 2013;Haeusler et al 2014;Liu et al 2014;Waite et al 2014). Additionally, there has been one report of a loss-of-function splice site mutation in C9orf72 causing ALS (Liu et al 2016). Furthermore, higher C9orf72 levels may have beneficial effects against neurodegeneration in humans (van Blitterswijk et al 2015;McGoldrick et al 2018).…”
mentioning
confidence: 99%